First Time Loading...

Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Updated: May 21, 2024

Wall Street
Price Targets

NZYM B Price Targets Summary
Novozymes A/S

There are no price targets for NZYM B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novozymes A/S Competitors:
Price Targets
4203
Sumitomo Bakelite Co Ltd
6% Upside
SHK
S H Kelkar and Company Ltd
4% Downside
NANX
Nanophase Technologies Corp
1% Upside
EMN
Eastman Chemical Co
9% Upside
069260
TKG Huchems Co Ltd
63% Upside
FCL
Fineotex Chemical Ltd
64% Upside
B39
Humble Group AB
19% Upside
TECHBND
Techbond Group Bhd
15% Upside

Revenue
Forecast

Revenue Estimate
Novozymes A/S

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

3%
Past Growth
-55%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Novozymes A/S

Operating Income forecast
is not available for
Novozymes A/S

Net Income
Forecast

Net Income Estimate
Novozymes A/S

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

0%
Past Growth
-56%
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NZYM B's stock price target?
Not Available

NZYM B doesn't have any price targets made by Wall Street professionals.

What is Novozymes A/S's Revenue forecast?
Projected CAGR
-55%

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

What is Novozymes A/S's Net Income forecast?
Projected CAGR
-56%

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.